4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-292546
Chief Operating Officer sold 10,000 shares at an average $41.58 ($415,798)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gault Cheryl Chief Operating Officer | 2026-06-30 | Sale 10b5-1 | −1,900 | $40.09 | $76,174 | 158,014 | D |
| Gault Cheryl Chief Operating Officer | 2026-06-30 | Sale 10b5-1 | −3,792 | $41.39 | $156,964 | 154,222 | D |
| Gault Cheryl Chief Operating Officer | 2026-06-30 | Sale 10b5-1 | −3,308 | $42.17 | $139,506 | 150,914 | D |
| Gault Cheryl Chief Operating Officer | 2026-06-30 | Sale 10b5-1 | −1,000 | $43.15 | $43,155 | 149,914 | D |
| Open-market sales · 10,000 sh · avg $41.58 · $415,798 | |||||||
Loading xslF345X06/ownership.xml…